[13]
In the present instance the crossexaminer avoided the pit which Hugessen, J.A., confirmed as such. It is perhaps a thin line, but in the instant case it will be recalled that Mr. Creber never once asked Mr. Dan the
name
of the sources of the nizatidine. Rather he sought to know whether the source or sources of the drug is or are, or will be, outside of Canada. It appears that the
Merck
case would have been differently decided on this point, if the cross-examiner there had crafted and confined the questions as did the cross-examiner here.